Abstract: An extensive multi-disciplinary literature examines the effects of learning one's HIV status on subsequent risky sexual behaviors. However, many of these studies rely on nonexperimental designs; use self-reported outcome measures, or both. In this study, we investigate the effects of a randomly assigned Voluntary Counseling and Testing (VCT) intervention on risky sexual behaviors and schooling investments among school-age females in Malawi. We find no overall effects on HIV, Herpes Simplex Virus (HSV-2), or test scores at follow-up. However, receiving a HIV-positive test result causes a large increase in the probability of contracting HSV-2, with stronger effects among those surprised by the HIV-positive test results. Similarly, those surprised by HIV-negative test results see a significant improvement in achievement test scores, consistent with increased returns to investments in human capital. We view the finding on increased HSV-2 prevalence among HIV-positive individuals as a caution to the conventional wisdom that those who learn they are HIV-positive will adopt safer sexual practices.
Voluntary Counseling and Testing (VCT) is one of the pillars of HIV prevention (Potts et al. 2008) . Recently, the U.S. Preventive Services Task Force released a draft recommendation statement suggesting that nearly everyone between the ages of 15-65 be screened for HIV (U.S.
Preventative Services Task Force 2012). One argument for universal HIV testing is due to recent findings indicating that HIV-positive individuals who immediately receive antiretroviral therapy (ART) significantly reduce their transmission risk to uninfected partners and experience lower morbidity and mortality rates than those receiving delayed treatment (Cohen et al. 2011) . A distinct argument suggests that HIV-positive individuals reduce risky sexual behaviors after learning their serostatus (Cassell and Surdo 2007; Gersovitz 2010; Fonner et al. 2012) , indicating that testing itself would be a means of decreasing subsequent sexual transmission of disease.
Despite the belief that increasing awareness of HIV status has prevention benefits, there are no studies that have shown population level reductions in the incidence of HIV or other sexually transmitted infections (STIs) as a result of VCT interventions (Potts et al. 2008) .
1 Several studies in public health and economics have presented VCT impacts by HIV serostatus. These studies generally show no effects of VCT on sexual behavior or seroconversion for HIV-negative individuals (Allen et al. 1992a; Weinhardt et al. 1999; Corbett et al. 2007; Thornton 2008; Fonner et al. 2012 ), but available evidence suggests that HIV-positive individuals reduce risky behaviors after testing (Allen et al. 1992b; Weinhardt et al. 1999; Boozer and Philipson 2000; Thornton 2008; Delavande and Kohler 2012; Fonner et al. 2012 ).
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The interdisciplinary literature summarized above is mainly based on self-reported data, which may be subject to social desirability bias (Allen et al. 2003; Minnis et al. 2009 ). 3 The possibility 1 Furthermore, there are no randomized controlled trials (RCT) that directly assess subsequent HIV transmission for VCT vs. non-VCT. Kamb et al. (1998) , using an RCT, assessed the effects of different modes of counseling for HIV-negative individuals on STI incidence, but everyone received an HIV test and learned their serostatus. More recently, Project Accept (HPTN 043) is assessing the effectiveness of community-based VCT relative to standard clinic-based VCT on community-level HIV incidence (http://www.cbvct.med.ucla.edu/overview.html). The Voluntary HIV-1 Counseling and Testing Efficacy Study Group (2000) found significant decreases in risky activity with non-primary partners for individuals and couples who received VCT. 2 de Paula et al. (2010) reports that an increase in the beliefs of being HIV-positive reduced extra-marital affairs among married men in Malawi. Beegle, Poulin and Shapira (2012) , using randomly assigned VCT in Malawi, find no effects on either sexual behavior or economic outcomes. Haile (2011) examines randomly assigned testing in Ethiopia and also finds limited impacts on sexual behavior and if anything finds that getting a negative test actually leads to more risky behavior. 3 In economics, Gong (2012) , which examines the effects of a randomly assigned VCT intervention on incident gonorrhea and chlamydia, is a notable exception. In public health, two studies of women presenting at prenatal and pediatric outpatient clinics in Rwanda provide evidence on STI incidence for HIV-positive women (Allen et al. 1992a) and HIV seroconversion for the uninfected partner in cohabiting couples with serodiscordant results (Allen et of bias may be particularly relevant in the case of VCT interventions. Revelation of HIV serostatus and the information provided in the pre-and post-test counseling sessions appear likely to alter the stigma of reporting risky sexual behaviors at follow-up, leading to a potentially biased estimate of the actual behavior change (Gong 2012) . Even objectively observed behavior such as the purchase of condoms in Thornton (2008) may be subject to this kind of bias. 4 In addition to these measurement limitations, the effects of testing are likely to display considerable heterogeneity across individuals. One strand of the literature in economics has focused primarily on the informational signal sent, suggesting that VCT should only have an effect on those who are 'surprised' by their HIV serostatus. In this case, the greatest effect will be found among those who believed they were HIV-negative (HIV-positive) but received a positive (negative) test result (Boozer and Philipson 2000) . In fact, these two groups may have offsetting behavioral responses to VCT, leading to small or no effects of testing on the entire population: in the extreme, the average treatment effect may be relevant for no one.
While this hypothesis indicates that people will change behavior only as a result of receiving new information, it does not tell us the direction in which behavior will change. The concept of 'fatalism' suggests that responses may be non-monotonic: individuals may increase their risky activity in response to increased HIV prevalence around them above a certain threshold (Kremer 1996; Kerwin 2012) . Learning one's own HIV-positive status can be seen as an extreme case, where the cost of risky sex becomes zero for the infected individual who may become fatalistic because she has 'nothing to lose'. Gong (2012) presents a simple model to suggest that the effects of VCT are, a priori, ambiguous: the response of a utility maximizing individual to new information about HIV infection will depend on her prior beliefs of HIV infection and the degree to which altruism affects her behavior. Given the widely documented 'transactional' nature of risky sexual activity in Malawi (Poulin 2007; Swidler and Watkins 2007) , the setting for this study, one might expect the direct benefits of risky activity to be high and altruism towards al. 1992b ), but both of these are prospective cohort studies comparing outcomes before and after VCT with no randomly assigned comparison group. The Voluntary HIV-1 Counseling and Testing Efficacy Study Group (2000) states that their RCT was not powered to detect effects on STIs, while another RCT was designed to assess HIV incidence among initially HIV-negative individuals and cannot comment on onward transmission from individuals who were HIV-positive at baseline (Corbett et al. 2007 ). 4 Self-reported data in arguably less sensitive subjects, such as school enrollment and hand washing (Halder et al. 2010; Ram et al. 2010) , have also been shown to be subject to social desirability bias.
casual partners to be low for some individuals. In such circumstances, it is possible that individuals who find out that they are infected with HIV may increase their risky sexual activity.
Economic theory also suggests the possibility of changes for a broader set of behaviors in response to testing. For instance, if learning one's HIV status leads to changes in subjective life expectancy, this may lead to changes in consumption, savings, and investments in human capital (Thornton 2012 ) -changes that are also likely to be moderated by people's beliefs about HIV infection prior to VCT (Yeatman 2009 , Goldstein et al. 2013 .
In this paper, we utilize objective outcome measures within a VCT experiment to test these hypotheses among young females in Malawi. Specifically, we are interested in the effects of VCT on two outcomes: risky sexual behavior and investments in human capital. We first examine the overall effect of HIV testing on the population, and then motivated by theory, examine both the effects of testing by HIV-status (i.e. the effects of an HIV-negative/positive test), as well as the effects of being surprised by the test result.
In order to minimize the risk of bias from self-reports, we use HSV-2 as our primary outcome measure for sexual behavior and achievement tests in mathematics, English reading comprehension, and Raven's Colored Progressive Matrices as our primary measure of investments in human capital. 5 We also collected data on the participants' prior beliefs regarding HIV infection.
Overall, we find no significant effects of VCT on HIV, HSV-2, or test scores. The lack of an overall effect is consistent with the existing literature that finds no effects among those who were HIV-negative at baseline -the group that constitutes 95% of our sample. However, the HSV-2 prevalence at follow-up among the small group of young women who received HIV-positive test results was 23 percentage points higher than HIV-positive individuals who did not receive VCT.
This increase is at odds with most previous studies, which suggest that those who learn they are HIV-positive adopt safer sex practices.
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Consistent with economic theory, the perverse effect of VCT is stronger among those surprised by HIV-positive tests, i.e. those who reported no chance of being infected with HIV at baseline. 5 In our sample of young females, we consider marginal investments in schooling to be the most important long-term decision, and focus on changes in achievement test scores to capture this effect. 6 The lone exception is a recent study by Gong (2012) , who used biomarker data from a VCT experiment in a highrisk urban sample in Kenya and Tanzania and found a similar increase in STI incidence among those infected with HIV.
Also in line with theory, we find that VCT can increase investments in one's own human capital.
Those surprised by HIV-negative tests, i.e. those who report some chance of HIV infection at baseline but discover that they are HIV-negative, perform significantly better in achievement tests -a finding supported by an increase in self-reported school enrollment among the same subgroup.
Our results suggest that VCT can lead to important changes in human capital investments by providing vital health information and add to a larger literature on the effects of informationinterventions (Nguyen 2008; Dupas 2010; Jensen 2010; Goldstein et al. forthcoming; Oster, Shoulson, and Dorsey, forthcoming) . Furthermore, our finding of increased STI risk among HIVpositive individuals who receive VCT serves as a caution to the assumption that such individuals will adopt safer sexual practices upon learning their serostatus. Finally, our study points to the importance of using objective outcome measures rather than self-reported behavior change when studying treatments that may differentially alter social desirability bias.
In the next section, we describe the setting of our study. Sections II and III describe the methods and our findings. Section IV provides a concluding discussion that includes the limitations of our study.
I. Setting
Malawi, which is a small and poor country in southern Africa, is the setting for this study VCT took place at the homes of the core respondents where they were invited to receive counseling and rapid testing for HIV, HSV-2, and syphilis by a trained counselor. 9 Overall acceptance of VCT was high at 98%, with no differences between the two study arms. Malawian nurses and counselors certified in conducting rapid HIV tests through the Ministry of Health HIV Unit HCT Counselor Certification Program conducted VCT. Testing and counseling was performed in a private location at or near the participant's house. Whole blood samples were 7 For more details on the cash transfer experiment and its impact evaluation, please refer to Baird, McIntosh and Özler (2011) . 8 Details of the randomization for the VCT experiment as well as specific VCT procedures can be found in . 9 Rapid tests for syphilis were only performed during the first round of VCT as its prevalence in this sample was found to be less than 1%. The effects of this intervention should be considered noting that the subjects were invited to receive counseling and testing not only for HIV but for HSV-2 and syphilis as well.
obtained using a finger-stick. The teams conducting VCT at follow-up were blinded to the testing treatment status of the subjects and were independent of the survey teams that conducted household surveys and administered achievement tests (discussed below). 10 Ethics review committees at the National Health Sciences Research Council (Malawi), the University of California at San Diego (USA), and George Washington University (USA) approved the study design.
The household survey data used in this paper were collected in two rounds, the second and third wave of the overall study. Economic theory suggests that changes in subjective life expectancy may lead to changes in human capital investments. Perhaps the most critical investment that adolescents make is the laborious work of building their own human capital. Because the returns from investments in schooling are largely realized in the distant future they appear particularly informative as to inter-temporal tradeoffs. To measure improvements in student achievement, mathematics and English reading comprehension tests were developed and administered to all study participants as part of the follow-up data collection effort in 2010. The tests were developed by a team of experts at the Human Sciences Research Council according to the Malawian curricula for these 10 VCT counselors could deduce the VCT treatment status of the subjects who had tested positive for HIV or HSV-2 at baseline. To avoid unnecessary burdens on the subjects, re-testing for the previously positive test was avoided in such circumstances, meaning that the VCT counselor could deduce that the individual had been tested before for the foregone STI test. Furthermore, to protect the privacy of all individuals, every individual in both the VCT and control groups were visited at follow-up: those who had tested positive for only one STI were tested for the other, while those who had tested positive for both were given a short survey. The counselors were blinded to the treatment status of everyone else, i.e. those in the VCT group who tested negative at baseline or those in the control group who were not tested at baseline. 11 There was also a household survey conducted between October 2007 and January 2008 which served as a baseline for the cash transfer intervention, but is not used for this analysis. 12 These surveys, as well as the achievement tests described below, are available from the authors upon request.
subjects for Standards 5-8 and Forms 1-2. 13 In addition, to measure cognitive skills, we utilized a version of Raven's Colored Progressive Matrices that was used in the Indonesia Family Life Survey (IFLS-2).
Objective measures of behavior change minimize the risk of social desirability bias in the estimated treatment effects. In addition, the intervention itself might change the self-reporting bias of those receiving VCT. Thus, compared with self-reported sexual behaviors, biological markers of unprotected sex are likely to be preferable. 14 In this paper, we utilize biomarker data on both HIV and HSV-2, collected during VCT. For educational outcomes, we utilize test score data on mathematics, English reading comprehension, and cognitive ability, as they are likely to provide a more accurate measure of human capital investments than self-reported attendance or educational expenditures. The percentages of correct answers across these three tests were averaged to create an overall percentage of correct answers and standardized to serve as our primary outcome.
We supplement these objective measures of behavior with self-reported data from the household survey. We use the subjective likelihood of HIV infection at baseline to examine the heterogeneity of VCT impacts by prior beliefs. 15 Finally, we examine impacts on the following self-reported outcomes: subjective probability of HIV infection, perceived life expectancy, sexual behaviors, and school enrollment at follow-up. Given the caveats regarding the potential of bias in impact estimates on self-reported behaviors, we use these secondary outcomes to complement our findings of VCT effects on STIs and test scores.
In a randomized experiment with multiple rounds of data collection, the internal validity of the findings depends crucially on whether the randomization was conducted properly and whether attrition from the study sample was independent of treatment status. Table 1 presents a summary of baseline demographic characteristics, and measures of sexual behavior and education. Overall, the samples in the two arms are similar, with no difference between them that is statistically significant at the 5% level out of 16 comparisons, and two differences (female-headed household and never had sex) significant at the 10% level. The average age at baseline is just under 17 and more than three quarters of the sample reported being enrolled in school -with the mean highest 13 In Malawi, there are eight grades in primary school (Standard 1-8) and four in secondary school (Form 1-4). 14 However, such proxies are also imperfect surrogates for HIV transmission (Padian et al. 2011). 15 Self-reports at baseline may still suffer from social desirability bias, but such misreporting should be orthogonal to treatment status as VCT was randomly assigned and both groups were untreated at baseline.
grade attended being Standard 8, i.e. the last year of primary school in Malawi. Less than a quarter of the sample reported being sexually active during the 12 months prior to baseline data collection, and thus, not surprisingly, less than 10% report any chance of being infected with HIV. Appendix Table A1 examines whether there is any differential attrition between the two study arms. The analysis indicates that the attrition in the control group is around 15% and treatment status is orthogonal to attrition from the sample.
We estimate the overall effects of VCT on HIV and HSV-2, educational achievement, and some selected self-reported outcomes using an intention-to-treat (ITT) estimator. We use a linear probability model:
where ij Y is the outcome of interest for individual i in treatment cluster j, ! is an indicator of whether the cluster is randomly assigned to receive VCT in 2009, and !"# is a set of K individual-level baseline characteristics. This small set of controls, !"# , includes age, an indicator for never having had sex, and school enrollment status at baseline, all of which are demeaned and fully interacted with the treatment indicator. These baseline controls are prognostic of STI status at follow-up and orthogonal to treatment assignment, and thus they substantially improve the precision of our estimates. 16 The error terms, !" , are clustered at the EA level, which accounts both for the design effect of our EA level treatment and the heteroskedasticity inherent in the linear probability model. Age-and stratum-specific sampling weights are used to make the results representative of the target population in the study area.
We also estimate the effect of VCT separately for those receiving HIV-positive and HIV- Below, we provide an informal description of how we estimate VCT effects on HSV-2 by baseline HIV-serostatus. Appendix A formally defines our estimator and describes the calculation of the bounds within which the true ITT lies.
Individuals in the control group who tested HIV-positive at follow-up fall into two sub-groups:
those who were HIV-positive at baseline and those who became infected with HIV between baseline and follow-up. 19 This implies that the counterfactual HSV-2 prevalence for the VCT treatment is contaminated by the presence of HIV-seroconverters: we would like to observe the follow-up HSV-2 prevalence among only those who were HIV-positive at baseline in the control group, but instead we observe it among them and HIV seroconverters. The bias caused by this latter group is a function of two quantities: its size in our sample and the HSV-2 prevalence among them. We can estimate the former by calculating the difference between the HIV 18 Both types of study designs can be found in the existing literature. Corbett et al. (2007) reports collecting venous or finger-prick blood or oral mucosal transudate for anonymous HIV testing from all employees at the 22 businesses that were recruited for their study. Similarly, an ongoing study assessing the impacts of VCT by Duflo, Dupas, and Sharma also utilized anonymous linked testing of all study participants at baseline (http://www.povertyactionlab.org/node/5649). On the other hand, The Voluntary HIV-1 Counseling and Testing Efficacy Study Group (2000) thought neither collecting serum and testing for HIV without giving the individuals the results at baseline, nor testing for HIV but not providing counseling to be ethical. Thornton (2008) overcomes this identification problem by collecting blood samples from the entire sample and providing randomly varying levels of incentives for individuals to come back and learn their test results two to four months after sample collection and by randomizing the location of the temporary centers where the study participants can obtain their results. However, it is important to note that such estimates are local average treatment effects on those individuals who would have only learned their results due to the incentive and would not have otherwise. The introduction of HIV incidence assays, which can detect recent infections, may also provide further improvements in this area. As described in detail below, our empirical approach allows us to estimate the intention-to-treat (ITT) effect and provide bounds on the value of the true ITT by simply offering VCT in some clusters and not in others. 19 The description we provide here is for the case of the HIV-positive group, but the argument is symmetric for the estimator for the HIV-negative group.prevalence in the control group at follow-up and the HIV prevalence in the treatment group at baseline. Both of these groups are untested, and the samples are comparable due to random assignment into treatment. Using only this quantity, we can then calculate bounds for how large the bias caused by HIV-seroconverters to the impact estimates of HSV-2 can possibly be, under two extreme scenarios: (i) all of the HIV-seroconverters are HSV-2 positive in the follow-up; or (ii) none of them are.
III. Results
Table 2 presents our main findings. It first reports estimates for outcomes objectively measured at follow-up (HIV, HSV-2, and achievement test results, unadjusted and adjusted, in columns 1-6), and then for outcomes measured using self-reports (beliefs on HIV infection, subjective life expectancy, sexual behavior, and school enrollment -all adjusted estimates -in columns 7-12).
Panel A contains VCT impacts on the entire sample and shows that VCT had no statistically significant effect on the prevalence of HIV, HSV-2, or test scores at follow-up. These null effects are measured fairly precisely: we would have been able to detect a 2.7 percentage point effect on HSV-2 prevalence (follow-up prevalence in the control group is 7.4%) and a 0.23 standard deviation effect on test scores with 95% confidence. When we examine self-reported data, we find no significant changes in subjective life expectancy, likelihood of HIV infection, selfreported school enrollment, or unsafe sex, although there is a small but statistically significant increase in the likelihood of being sexually active during the past 12 months. Hence, overall, our findings suggest that the VCT intervention did not have any significant effects on STI risk or investments in human capital in the study population.
Panel A shows that the follow-up HIV prevalence in our sample of school-age girls and young women is fairly small at approximately 5%, indicating that more than 95% of the VCT group received a HIV-negative test result at baseline. Panel B shows that the VCT impacts among this group are generally very similar to those among the entire sample: VCT caused no changes in HSV-2 risk or in achievement test scores among this group, although they assign a lower average probability of being infected with HIV at follow-up and report a slightly higher number of sexual partners over the past 12 months.
However, when we examine the effects of VCT on those who tested HIV-positive at baseline, the story is starkly different (Panel C). Among the 73 HIV-positive individuals in our sample, the follow-up prevalence of HSV-2 is 23.1 percentage points higher in the VCT group than the control group mean of 25.5% --statistically significant at the 10% level.
20 Self-reports suggest changes in subjective beliefs as well: those in the VCT arm who receive HIV-positive tests assign a higher average probability to being HIV-positive at follow-up. 21 The self-reported outcomes on sexual behavior suggest some increase in sexual activity and the number of partners during the past 12 months but none of these variables is statistically significant. We don't find any significant effects on test scores.
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As described earlier, our naïve estimator of VCT impacts by baseline HIV status is biased by the presence of HIV-seroconverters among the counterfactual group at follow-up. To assess whether the VCT effect on HSV-2 prevalence among the HIV-positive subgroup is robust to this issue, we conduct a bounding exercise, which was summarized in the previous section and formally outlined in Appendix A. 23 While the lower and upper bounds for the true ITT estimate can be calculated analytically, in order to provide standard errors on the bounds we calculate them empirically. We do this by repeatedly and randomly excluding the expected number of HIV-seroconverters from our analysis and recalculating the VCT effect on HSV-2. The baseline HIV prevalence in the VCT group is 3.96% while the follow-up HIV prevalence in the control group is 5.03%. Neither of these figures is affected by VCT as they both reflect prevalence rates in each study arm prior to VCT. The difference between these two figures, which is equal to the 20 The adjusted estimate is very similar at 24.6 percentage points and significant at the 1% level. 21 While the average VCT effect on beliefs of HIV infection is strong and statistically significant, 43% of those who received HIV-positive test results reported no (zero) chance of being infected with HIV at the follow-up survey. This finding is unlikely to be due to the testing procedures. As detailed in the web appendix of , those who tested positive with one rapid test received a second independent test using a different test kit. On the very unlikely event that the two test results were discordant, a third test was administered to break the tie. It is consistent with two other studies from Malawi, both of which find that approximately 40% of individuals who received HIV-positive test results through a VCT intervention reported no likelihood of being infected in a followup survey (Thornton 2012; Delavande and Kohler 2012) . 22 The reader should note the limited statistical power of the impact analysis among this subgroup due to its small size in our sample. We have a total of 73 HIV-positive individuals in our analysis, which is similar in size to Thornton (2012) who uses a sample of 79 HIV-positive individuals, and Delavande and Kohler (2012) who use a sample of 97 HIV-positive individuals. Gong (2012) , using data on an older sample of people who were seeking HIV-related services, analyzes a sample of 465 HIV-positive individuals. 23 We do not present the results of the bounding exercise for the HIV-negative group because the small number of HIV-seroconverters forms a negligible share of the sample of 1,607 HIV-negative individuals and, hence, does not bias our estimates in any meaningful way.
estimated HIV incidence rate, implies that, of the 40 individuals in the control group who tested HIV-positive at follow-up, 32 are expected to have been HIV-positive at baseline and eight to have seroconverted between the two VCT rounds. To estimate a lower bound VCT effect, we randomly exclude eight HSV-2-negative individuals from the control group, rerun the adjusted regression described in equation (1), record the ITT estimate and its standard error, and repeat this 500 times. 24 Repeating the same exercise, this time randomly excluding eight HSV-2-positive individuals from the control group 500 times, yields the upper bound ITT estimate. Table 3 presents the results and shows that the lower bound estimates of the VCT effect is 0.224 while the upper bound estimate is 0.328 -both statistically significant at the 1% level Table 2 is robust to extreme assumptions about the HSV-2 status of HIV-seroconverters.
We conclude our empirical analysis by testing the hypothesis that the effects of HIV-positive (negative) tests should be concentrated among those who considered themselves at no (some) risk of HIV at baseline because VCT should lead to behavior change only if it is providing new information.
25 Table 4 provides support for this hypothesis. Panel A presents VCT effects for those surprised by their HIV-negative status: the first four columns show the effects on HSV-2 and test scores (unadjusted and adjusted) while the remaining columns show effects on the selfreported outcome measures (adjusted) presented in Table 2 . 26 We find an economically meaningful and statistically significant increase in achievement test scores in this subgroup: the unadjusted and adjusted estimates of VCT impact on test scores are 0.487 and 0.400 standard deviations, respectively -both significant at the 5% level. Self-reported outcomes point to the revelation of new, important information on health and increased investment in schooling among as potential channels for this finding: the young women in this subgroup are 12.3 percentage 24 This simulation produces an average HIV prevalence of 4.03% in the control group at baseline -very close to the 3.96% figure in the VCT group at baseline.
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Appendix Tables A4 and A5 show baseline balance among these sub-groups. 26 We define this subgroup as those who reported some likelihood of being infected with HIV prior to participating in VCT and found out otherwise. Similarly we define those surprised by their HIV-positive status as those who reported no chance of being infected with HIV prior participating in VCT but tested positive. points less likely to think they're HIV-positive (compared to a control mean of 15.9%; pvalue=0.000) and 13.3 percentage points more likely to report being enrolled in school at followup (compared to a control mean of 29.5%; p-value=0.158). The impact estimates on HSV-2 are in the expected direction but not statistically significant.
Panel B presents VCT effects for those surprised by their HIV-positive status. The unadjusted and adjusted VCT effects on HSV-2 prevalence in this subgroup are 0.299 and 0.215, respectively -both significant at the 5% level. Individuals in this group are more than 50 percentage points more likely to think they're infected with HIV at follow-up (compared with less than 2% in the control group; p-value=0.000). The impact estimates for test scores are, again, in the expected direction but not statistically significant. We find no significant impacts on any of the other self-reported outcomes. The reader should note, however, that the size of this subgroup is small and the impact estimates are accordingly imprecise.
IV. Concluding Discussion
We conducted a cluster randomized VCT intervention among young females in Malawi to disentangle its effects on risky sexual behavior and human capital investments. While VCT plays an unambiguously important role as a gateway to ART and, hence, would have indirect effects on HIV transmission through suppressed infectiousness after the start of therapy, its direct behavioral effects appear to be complex and not uniformly protective. Our main finding is that while VCT has no overall effect on STI risk or achievement test scores, it does have, consistent with economic theory, heterogeneous effects in subgroups. Among those who discover that they are HIV-positive, the risk of HSV-2 infection at follow-up increases substantially. On the other hand, individuals surprised by HIV-negative test results experienced a significant improvement in achievement test scores.
Until very recently, the literature on the effects of VCT on subsequent sexual behavior almost uniformly suggested that it caused HIV-positive individuals to become safer, not more risky.
However, this study and Gong (2012) , which share random assignment of VCT and the use of STI biomarkers as primary outcomes, come to the opposite conclusion. The sample in Gong (2012) consists of male and female adults seeking HIV-related services in Kenya and Tanzania in the mid-1990s, while our study examines a random sample of young females in Malawi in 2009. The common findings in these two studies, which utilize independent data sets from different countries, decades, and demographic groups, cast some doubt on the assumption that standard VCT interventions have direct prevention benefits through behavior change. We suggest that caution is warranted in interpreting findings from VCT studies that do not simultaneously tackle both the endogeneity of VCT and the risk of bias from self-reported sexual behavior data.
Our study has three main limitations. First, the small sample size, especially for the subgroup analysis of the HIV-positive group, increases the chance of baseline imbalance for our primary outcome measures. Given the study design, whereby baseline STI status is unknown in the control group, it is impossible to demonstrate balance for HIV and HSV-2. However, we note that the main findings are robust to the inclusion of baseline covariates that are prognostic of HSV-2 infection at follow-up. Second, we don't have the ideal study design required to assess VCT impacts by HIV serostatus, which requires collecting blood samples from all study participants at baseline but not informing the control group of their HIV serostatus. We show that infections. We find this to be unlikely in this study as our data show no indications of such serosorting among HSV-2 seroconverters in the VCT arm.
28 27 With the proliferation of rapid HIV tests that have high sensitivity and specificity, the ideal research design is likely to become less common in the future. We consider our estimator and the bounding exercise to be a modest methodological contribution. 28 An examination of the answers of HIV-positive HSV-2 seroconverters to follow-up survey questions about their sexual partners reveals that (i) all of them attach either 'no likelihood or 'low likelihood that their partners are HIVpositive; (ii) none of them think that their partner had other sexual partners while they were together; (iii) only half of them report that their partner was ever tested for HIV; and (iv) they all had age appropriate partners. Furthermore, the distributions of these variables are similar both among all of those in the VCT group who tested HIV-positive at baseline and among those in the control group who tested HIV-positive at follow-up. Another possibility is that individuals who found out they are HIV-positive switched to oral sex to protect their partners. We find this explanation also unlikely since the self-reported likelihood of receiving oral sex by men is very small in Malawionly 2% of rural men and 11% of urban men report ever having received oral sex. Furthermore, men substantially overestimate the probability of HIV infection through oral sex, indicating that it would not necessarily be seen as safer sex (Kerwin 2012; Kerwin, Thornton and Foley 2012) .
Keeping these limitations in mind, our study makes some contributions to the literature. Using survey questions designed to test several hypotheses regarding the effects of VCT, we find support for the hypothesis that VCT effects are concentrated among those 'surprised' by HIV test results, both in terms of sexual behavior and educational achievement, the latter of which is consistent with increased effort and investment in human capital in anticipation of a longer, healthier life. This finding suggests that VCT can affect important investment decisions among young individuals by revealing an HIV-negative status to those who previously thought they might be infected with HIV. This finding also suggests that exposure to infection risk and uncertainty about HIV status may cause young people to lower their investments in education.
These insights regarding the information signal provided by VCT help explain the main findings in Table 2 . Among this young population, most individuals have no expectation of being HIV-positive, so an HIV-negative test result does not surprise many. This is consistent with finding no overall effect of VCT among the HIV-negative group while finding an improvement in educational achievement once we limit our analysis to those surprised by an HIV-negative test. Similarly, an HIV-positive test result is an unwelcome surprise to many in our sample, which explains the large effects of VCT on HSV-2 among the entire HIV-positive group.
The troubling perverse effect of HIV-positive test results on HSV-2 serves as a caution to practitioners and merits careful consideration in policy terms. Following the logic presented in Gong (2012) , this result is suggestive of high short-term benefits from risky activity and low altruism towards marginal partners -a scenario consistent with transactional sex. If such relationships are partially to blame for this finding, policies that reduce transactional sex may also reduce these unwanted effects of VCT. Our results also suggest that standard VCT interventions, which simply convey HIV-status and provide brief pre-and post-test counseling sessions, may be insufficient to cause declines in risky sexual activity among those who find out those who HIV seroconvert in between the two rounds if no testing occurred (throughout this appendix we use a tilde to indicate quantities that are unobserved). Each of these three groups has a population prevalence, where , and by the properties of randomization and the fact that strata are defined in the absence of testing, these quantities are the same in the testing treatment and control. We observe as the prevalence rate in the treatment in the baseline, as one minus the prevalence rate in the control at follow-up, and as the difference between these two quantities.
The quantity that we wish to estimate is the causal effect of an HIV-positive test on the HSV-2 prevalence rate, which would be given by:
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While we can calculate the fraction of the sample that seroconverted in the control group, we cannot tell which specific (HIV-positive at follow-up) individuals belong to this group and hence we cannot separately measure the quantities or , only the HSV-2 prevalence in these combined groups . 29 The estimation of bounds for the causal effect of an HIV-negative test is similar and not detailed here.
Therefore, what we are able to measure directly is the 'Estimated' :
This shows that the resulting estimand is a weighted average of the correct ITT and the incorrect estimate that we would get by subtracting the outcome among seroconverters from the outcome among tested always-positives. This expression will equal the correct ITT either if (there are no seroconverters) or if (the seroconverters look just like the control always-positives). Hence, this expression gives us a way to understand how this imperfect counterfactual distorts the quantity that we estimate relative to the true ITT. Clearly, as these bounds converge to the estimated value, and .
This technique is the analogue to Lee bounds (Lee 2009) , where rather than facing attrition we face the addition of a new group whose outcomes may be different from those within the counterfactual we wish to form. These bounds can be formed with no assumptions beyond simple random assignment. (2) shows the means for the tested group. Column (3) presents the p-value on the difference between the two means. All variables are weighted to make them representative of the target population in the study EAs with robust standard errors clustered at the EA level to calculate the p-value. (2) shows the means for the tested group. Column (3) presents the p-value on the difference between the two means. All variables are weighted to make them representative of the target population in the study EAs with robust standard errors clustered at the EA level to calculate the p-value. (2) shows the means for the tested group. Column (3) presents the p-value on the difference between the two means. All variables are weighted to make them representative of the target population in the study EAs with robust standard errors clustered at the EA level to calculate the p-value. (2) shows the means for the tested group. Column (3) presents the p-value on the difference between the two means. All variables are weighted to make them representative of the target population in the study EAs with robust standard errors clustered at the EA level to calculate the p-value. Notes: Regressions are OLS models with robust standard errors clustered at the EA level. All regressions are weighted to make them representative of the target population in the study EAs. The achievement test score is the average percent across math, English and cognitive tests (standardized). The subjective likelihood of HIV infection takes on a value from 0 to 1 where zero is no self-reported chance of HIV infection. Risky sex takes on a value of 1 if the respondent does not always use condoms with all partners, and is zero for those who always use condoms or have not engaged in sexual activity in the past 12 months.
Appendix
Regressions that include controls include the following: age, an indicator for never having had sex, and school enrollment status at baseline, all of which are demeaned and fully interacted with the treatment indicator. Parameter estimates statistically different than zero at 99% (***), 95% (**), and 90% (*) confidence.
Panel C: VCT Impacts on the HIV-Positive Sample Notes: Estimated ITT in column 1 is identical to the estimate in column 2, Panel C of Table 2 . To estimate the lower bound ITT, we randomly exclude 8 HSV-2-negative individuals from the control group, which is the expected number of HIV seroconverters in the control group, rerun the regression described in equation (1), record the ITT estimate β and its standard error, and repeat this 500 times. The mean values of the coefficient estimate and its standard error are reported in column 2. Repeating this simulation exercise, this time randomly excluding 8 HSV-2-positive individuals from the control group, we calculate the upper bound ITT, which is reported in column 3. Please see details in Results section and Appendix A. Regressions are OLS models with robust standard errors clustered at the EA level. All regressions are weighted to make them representative of the target population in the study EAs. All regressions include the following controls: age, an indicator for never having had sex, and school enrollment status at baseline, all of which are demeaned and fully interacted with the treatment indicator. Parameter estimates statistically different than zero at 99% (***), 95% (**), and 90% (*) confidence. Regressions are OLS models with robust standard errors clustered at the EA level. All regressions are weighted to make them representative of the target population in the study EAs. The achievement test score is the average percent across math, English and cognitive tests (standardized). The subjective likelihood of HIV infection takes on a value from 0 to 1 where zero is no selfreported chance of HIV infection. Risky sex takes on a value of 1 if the respondent does not always use condoms with all partners, and is zero for those who always use condoms or have not engaged in sexual activity in the past 12 months. Regressions that include controls include the following: age, an indicator for never having had sex, and school enrollment status at baseline, all of which are demeaned and fully interacted with the treatment indicator. Parameter estimates statistically different than zero at 99% (***), 95% (**), and 90% (*) confidence 
